CATALYST PHARMACEUTICALS, INC.: capex
| Value | {"amount": 556000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | CATALYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bd5935c7-0e3c-4fa1-a90f-d885ad9a7f90
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-027714Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001369568/capex/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bd5935c7-0e3c-4fa1-a90f-d885ad9a7f90
History
- no predecessors — first report